Targeting eosinophils in allergy, inflammation and beyond.
about
Role of biologics in severe eosinophilic asthma - focus on reslizumabEosinophilic bioactivities in severe asthmaEosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary diseaseAeroplysinin-1, a Sponge-Derived Multi-Targeted Bioactive Marine DrugNovel Therapies for Eosinophilic DisordersActivation states of blood eosinophils in asthmaUpdate on anticytokine treatment for asthmaSynthesis, Pharmacological Profile and Docking Studies of New Sulfonamides Designed as Phosphodiesterase-4 InhibitorsInhalation of rod-like carbon nanotubes causes unconventional allergic airway inflammationEvidence from a large-scale meta-analysis indicates eczema reduces the incidence of gliomaRegulatory T Cells Control Th2-Dominant Murine Autoimmune GastritisCrosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity.Eosinophil Activation Status in Separate Compartments and Association with AsthmaInnate immunity is a key factor for the resolution of inflammation in asthmaDusp5 negatively regulates IL-33-mediated eosinophil survival and functionCharacterisation of leukocytes in a human skin blister model of acute inflammation and resolutionWogonin induces eosinophil apoptosis and attenuates allergic airway inflammationc-FLIP protects eosinophils from TNF-α-mediated cell death in vivoMolecular, genetic, and cellular bases for treating eosinophilic esophagitis.Biologic therapies targeting eosinophils: current status and future prospects.High fat diet causes depletion of intestinal eosinophils associated with intestinal permeability.Circulating Human Eosinophils Share a Similar Transcriptional Profile in Asthma and Other Hypereosinophilic Disorders.Co-Infection and Wild Animal Health: Effects of Trypanosomatids and Gastrointestinal Parasites on Coatis of the Brazilian PantanalGranulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic ColitisHow I treat hypereosinophilic syndromes.Simvastatin Inhibits IL-5-Induced Chemotaxis and CCR3 Expression of HL-60-Derived and Human Primary EosinophilsChromones: A Promising Ring System for New Anti-inflammatory Drugs.Eosinophils in vasculitis: characteristics and roles in pathogenesis.Loki zupa (Luooukezupa) decoction reduced airway inflammation in an OVA-induced asthma mouse model.Virus-like particles presenting interleukin-33 molecules: immunization characteristics and potentials of blockingIL-33/ST2 pathway in allergic airway inflammationMechanisms of Disease of Eosinophilic Esophagitis.Structural basis for sulfation-dependent self-glycan recognition by the human immune-inhibitory receptor Siglec-8CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptorsActivated mouse eosinophils protect against lethal respiratory virus infection.The Peripheral Blood Eosinophil Proteome.Measurement science in the circulatory system.Effects of chemokine receptor 3 gene silencing by RNA interference on eosinophils.Eosinophil activities modulate the immune/inflammatory character of allergic respiratory responses in mice.Surfactant protein SP-D modulates activity of immune cells: proteomic profiling of its interaction with eosinophilic cells.Biological Modulators in Eosinophilic Diseases.
P2860
Q26738503-F9FAF5A8-6D17-4BB0-A7BC-7119790B624CQ26744175-643D869E-2A34-4B10-A00F-21A8A2EFF24EQ26771819-6EE62C16-E667-4DE6-B541-AFA9FDCFC728Q26772014-2027D8ED-9DBD-42E1-840D-1309E285C265Q26799600-E52475E6-783C-4C21-BBAD-EEEA7A9CF4E4Q26853383-6BA2BF66-CE0D-43AC-BD37-D8006B1AD96BQ27013617-F0D9DE17-2D1F-4802-8001-469DB6134755Q27322207-E6ABDCE4-67C6-454F-9556-1A46B931E7FAQ28396866-CF893D31-5E00-40CF-84CC-D95DD4A5D9E1Q29248257-B68EA5DC-60CA-48F8-B506-A58D13058C21Q30276673-76542BF0-6A41-417E-AD5C-51EF4CC67F35Q33707961-FC3AAD4E-7521-4B0D-BC5D-207311FDC786Q33785627-2CE02AB2-C7ED-4BAA-8AAD-5E2ED7E97F64Q34465047-66688DE0-0934-45F6-9F21-7376413AB294Q35109566-8455AD41-4E96-4A3B-9BA4-4DC355220D16Q35113006-B77F6BBD-0548-4CC1-9F4A-80207A999DFBQ35262027-F2EF1BBF-FAB0-480F-96B3-91E08367501BQ35354622-12A122DF-D65B-4A6B-BF7F-3EB287586A5AQ35537424-1D2901EE-CF62-43C4-9F10-992AE0A1EEFFQ35565533-F0D5CBEC-A6D5-4DD6-A8AB-BA3AFFA016FDQ35594503-CDF469D7-D66F-4693-9704-27DABBA83D3BQ35829354-EAF3163E-AF2E-47C0-8E8A-211188CA951FQ35866544-2AC3FA99-482C-4A3B-B995-DC09B64A1101Q35898996-C1D82B9E-06B6-4744-BBEF-647B5CFA053BQ36000858-88EA3E4F-2729-4576-8452-FCD8ADAF0E23Q36044812-713B6737-8116-4C59-B0A0-DF522A0232ACQ36133463-09E83CAC-CBED-44E3-AD6D-DFD76479FB5DQ36847447-96671B95-5DD1-4F8E-B2F7-13F4E36EE87FQ36853754-C4E75F00-61ED-48C0-97DE-4F9C69356450Q36978476-A21EC129-9DB9-497A-9B63-B25FD79C1696Q37031313-5137E285-D6AF-4933-AAC3-AE972BE454C3Q37126813-C0B33645-2895-4238-BC96-4820C7FD7923Q37138955-8159DC96-5A9B-4823-A978-4DD86737E900Q37535254-EF6EA97E-B629-44EC-8CFA-57AAA6085F02Q37574380-A6655251-3D26-496E-BDB6-5E939746C430Q37592842-7A8E7CB2-6649-4988-A5CB-6DFD69AB74ABQ37594081-873F4010-7292-4D3D-BE70-F7B68A4AE1EEQ37620380-0A9ED0F1-FF26-44FF-B373-17BF3571FC12Q38201782-03F27899-EB2B-4B6D-AB4E-50CD47ACC7D8Q38240474-74BC0AF1-F7CF-43A6-8A99-D88FCDA6EBEC
P2860
Targeting eosinophils in allergy, inflammation and beyond.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting eosinophils in allergy, inflammation and beyond.
@en
type
label
Targeting eosinophils in allergy, inflammation and beyond.
@en
prefLabel
Targeting eosinophils in allergy, inflammation and beyond.
@en
P2860
P356
P1476
Targeting eosinophils in allergy, inflammation and beyond.
@en
P2093
Marc E Rothenberg
Patricia C Fulkerson
P2860
P2888
P304
P356
10.1038/NRD3838
P577
2013-01-21T00:00:00Z
P6179
1015594094